1. Home
  2. DNLI vs KLIC Comparison

DNLI vs KLIC Comparison

Compare DNLI & KLIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • KLIC
  • Stock Information
  • Founded
  • DNLI 2013
  • KLIC 1951
  • Country
  • DNLI United States
  • KLIC United States
  • Employees
  • DNLI N/A
  • KLIC N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • KLIC Semiconductors
  • Sector
  • DNLI Health Care
  • KLIC Technology
  • Exchange
  • DNLI Nasdaq
  • KLIC Nasdaq
  • Market Cap
  • DNLI 2.1B
  • KLIC 1.7B
  • IPO Year
  • DNLI 2017
  • KLIC N/A
  • Fundamental
  • Price
  • DNLI $14.46
  • KLIC $37.40
  • Analyst Decision
  • DNLI Strong Buy
  • KLIC Strong Buy
  • Analyst Count
  • DNLI 15
  • KLIC 4
  • Target Price
  • DNLI $33.85
  • KLIC $48.75
  • AVG Volume (30 Days)
  • DNLI 1.7M
  • KLIC 537.9K
  • Earning Date
  • DNLI 08-11-2025
  • KLIC 08-06-2025
  • Dividend Yield
  • DNLI N/A
  • KLIC 2.19%
  • EPS Growth
  • DNLI N/A
  • KLIC N/A
  • EPS
  • DNLI N/A
  • KLIC 0.11
  • Revenue
  • DNLI N/A
  • KLIC $657,842,000.00
  • Revenue This Year
  • DNLI N/A
  • KLIC N/A
  • Revenue Next Year
  • DNLI $323.34
  • KLIC $16.25
  • P/E Ratio
  • DNLI N/A
  • KLIC $340.14
  • Revenue Growth
  • DNLI N/A
  • KLIC N/A
  • 52 Week Low
  • DNLI $10.57
  • KLIC $26.63
  • 52 Week High
  • DNLI $33.33
  • KLIC $52.08
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 53.04
  • KLIC 62.40
  • Support Level
  • DNLI $12.92
  • KLIC $31.32
  • Resistance Level
  • DNLI $15.06
  • KLIC $37.87
  • Average True Range (ATR)
  • DNLI 0.78
  • KLIC 1.25
  • MACD
  • DNLI 0.06
  • KLIC 0.47
  • Stochastic Oscillator
  • DNLI 72.03
  • KLIC 92.82

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About KLIC Kulicke and Soffa Industries Inc.

Kulicke & Soffa Industries Inc is a United States-based company that is principally engaged in designing, manufacturing, and selling capital equipment and expendable tools that are used for assembling semiconductor devices. The company has four reportable segments which includes Ball Bonding Equipment, Wedge Bonding Equipment, Advanced Solutions, and Aftermarket Products and Services. Its Ball Bonding Equipment segment which generates the majority of the revenue for the company includes results of the company from the design, development, manufacture and sale of ball bonding equipment and wafer level bonding equipment. The majority of its customers are located in the Asia-pacific region.

Share on Social Networks: